Cytech Group Co., Ltd. (SHE:301557)
China · Delayed Price · Currency is CNY 74.51
-2.12 (-2.77%)
At close: Oct 9, 2026
Cytech Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,199 | 1,160 | 1,042 | 862.51 | 732.85 | 607.57 |
Other Revenue | 35.93 | 18.74 | 7.84 | 8.8 | 6.95 | 12.03 |
| 1,235 | 1,178 | 1,050 | 871.31 | 739.8 | 619.6 | |
Revenue Growth | 12.16% | 12.20% | 20.53% | 17.78% | 19.40% | -27.71% |
Cost of Revenue | 997.87 | 921.58 | 783.13 | 656.6 | 551.22 | 470.96 |
Gross Profit | 237.2 | 256.68 | 267.04 | 214.71 | 188.58 | 148.64 |
Selling, General & Admin | 87.72 | 92.34 | 78.43 | 61.49 | 47.74 | 46.82 |
Research & Development | 43.22 | 36.74 | 29.31 | 26.94 | 26.36 | 18.28 |
Other Operating Expenses | 4.93 | 3.97 | 6.29 | 3.05 | 5.15 | 5.46 |
Operating Expenses | 144.97 | 148.25 | 127.85 | 103.66 | 79.74 | 69.3 |
Operating Income | 92.23 | 108.43 | 139.19 | 111.05 | 108.84 | 79.34 |
Interest Expense | -6.74 | -6.93 | -8.24 | -5.5 | -2.76 | -5.77 |
Interest & Investment Income | 0.35 | 0.38 | 0.46 | 0.5 | 0.26 | 0.3 |
Currency Exchange Gain (Loss) | - | - | - | -0 | - | - |
Other Non Operating Income (Expenses) | -0.15 | -1.16 | 2.47 | 0.17 | -0.29 | -0.18 |
EBT Excluding Unusual Items | 85.69 | 100.71 | 133.88 | 106.22 | 106.05 | 73.69 |
Gain (Loss) on Sale of Investments | -3.27 | -2.62 | -6.85 | -6.17 | -3.94 | -2.26 |
Gain (Loss) on Sale of Assets | 0.39 | 0.49 | -0.57 | -0.7 | 0.03 | 0.28 |
Asset Writedown | -0.05 | -0.48 | -0.6 | -0.13 | -0.16 | -0.03 |
Other Unusual Items | 1.32 | 3.74 | 1.88 | 0.46 | 6.98 | 5.48 |
Pretax Income | 84.08 | 101.85 | 127.75 | 99.68 | 108.96 | 77.16 |
Income Tax Expense | 6.57 | 12.96 | 22.52 | 17.08 | 21.42 | 15.34 |
Earnings From Continuing Operations | 77.51 | 88.9 | 105.23 | 82.6 | 87.54 | 61.82 |
Net Income | 77.51 | 88.9 | 105.23 | 82.6 | 87.54 | 61.82 |
Net Income to Common | 77.51 | 88.9 | 105.23 | 82.6 | 87.54 | 61.82 |
Net Income Growth | -17.71% | -15.52% | 27.39% | -5.64% | 41.60% | -40.66% |
Shares Outstanding (Basic) | 64 | 60 | 46 | 46 | 47 | 46 |
Shares Outstanding (Diluted) | 64 | 60 | 46 | 46 | 47 | 46 |
Shares Change | 24.27% | 28.13% | 0.07% | -0.33% | 0.68% | 10.38% |
EPS (Basic) | 1.21 | 1.49 | 2.26 | 1.78 | 1.88 | 1.34 |
EPS (Diluted) | 1.21 | 1.49 | 2.26 | 1.78 | 1.88 | 1.34 |
EPS Growth | -33.79% | -34.07% | 27.31% | -5.32% | 40.64% | -46.24% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -106 | -213.01 | -52.04 | -44.64 | 3.72 | -89.87 |
Free Cash Flow Per Share | -1.65 | -3.58 | -1.12 | -0.96 | 0.08 | -1.94 |
Dividend Per Share | 0.643 | 0.643 | 0.786 | - | - | - |
Dividend Growth | -18.18% | -18.18% | - | - | - | - |
Gross Margin | 19.20% | 21.78% | 25.43% | 24.64% | 25.49% | 23.99% |
Operating Margin | 7.47% | 9.20% | 13.25% | 12.75% | 14.71% | 12.80% |
Profit Margin | 6.28% | 7.54% | 10.02% | 9.48% | 11.83% | 9.98% |
Free Cash Flow Margin | -8.58% | -18.08% | -4.96% | -5.12% | 0.50% | -14.50% |
EBITDA | 118.89 | 134.88 | 163.11 | 127.47 | 135.13 | 102.56 |
EBITDA Margin | 9.63% | 11.45% | 15.53% | 14.63% | 18.27% | 16.55% |
D&A For EBITDA | 26.66 | 26.45 | 23.92 | 16.42 | 26.29 | 23.22 |
EBIT | 92.23 | 108.43 | 139.19 | 111.05 | 108.84 | 79.34 |
EBIT Margin | 7.47% | 9.20% | 13.25% | 12.75% | 14.71% | 12.80% |
Effective Tax Rate | 7.82% | 12.72% | 17.63% | 17.13% | 19.66% | 19.88% |
Revenue as Reported | 1,235 | 1,178 | 1,050 | 871.31 | - | - |